Literature DB >> 3812231

Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome.

R A Freedman, K P Anderson, L S Green, J W Mason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3812231     DOI： 10.1016/s0002-9149(87)80096-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  13 in total

Review 1.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

2.  Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac muscles.

Authors:  W E Colbert; J A Turk; P D Williams; M K Buening
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

3.  Association of intravenous erythromycin and potentially fatal ventricular tachycardia with Q-T prolongation (torsades de pointes).

Authors:  R A Schoenenberger; W E Haefeli; P Weiss; R F Ritz
Journal:  BMJ       Date:  1990-05-26

Review 4.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 5.  [Ventricular tachyarrhythmia as a side effect of pharmacotherapy].

Authors:  Thomas Demming; Hendrik Bonnemeier
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-05-09

Review 6.  Astemizole. A nonsedating antihistamine with fast and sustained activity.

Authors:  M M Janssens
Journal:  Clin Rev Allergy       Date:  1993

Review 7.  Drug interactions with cisapride: clinical implications.

Authors:  E L Michalets; C R Williams
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

Review 8.  Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions.

Authors:  D A Flockhart; Z Desta; S K Mahal
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

Review 9.  Possible risk for cardiac arrhythmia related to intravenous erythromycin.

Authors:  W E Haefeli; R A Schoenenberger; P Weiss; R Ritz
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 10.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.